化学プロセス強化のためのマイクロリアクション技術（MRT）

Abstract

MicroReaction Technology (MRT), a solution for process intensification, is evolving from R&D lab use to chemicals production, leading to new products and new companies' strategies, which widen technology possibilities and increases users' number.

The change of paradigm from batch production to continuous flow is occurring. Indeed, 20 to 30 chemical plants are now running with microstructured elements. Large chemical and pharmaceutical companies are increasingly considering MRT as a process intensification solution to solve some of their current processing problems for lab research and debottlenecking production.

The current market for microreaction products is low, but exponential potential is forecasted in the coming years, provided that proof of technical and economical efficiency drives the change of paradigm.

Currently, microreaction modules sold as stand-alone modules account for 50% of the market, the other half being the sale of integrated systems. Fine & specialty chemicals businesses represent the largest part of MRT market which is today at its beginning. The wider use of MRT is going behind fine & specialty chemicals frontiers to pharmaceuticals, commodity chemicals and petrochemicals. Major MRT players as the Institute fur Mikrotechnik Mainz (IMM) and its spin-offs CPC, Mikroglas, Ehrfeld BTS, but also Syrris and Velocys are ever gaining new customers. However, new players are entering the market presenting new offers.

Who should buy the report:

• Executives of companies active in the development of microreaction products or assessing their entry in this field
• Executives of engineering companies, that could broaden their process intensification offer with microreaction
• R&D managers or Production leaders of chemical companies, that want to discover a new technology (products, players, market)

Benefits:

• To understand MRT market status and evolution
• To get to know products, suppliers and users

The report gives answer to the following questions:

• How is MRT going from lab to production: players involved, products examples of realizations?
• What are the key know how of MRT suppliers?
• What are key success factors to succeed in MRT market?

Companies in the report

Akzo Nobel, Atotech, BASF, Bayer, Bristol Myers Squibb, CEA, Charts Industry, Clariant, Corning, CPC, Degussa, Dow Chemical, DSM, Dupont, Eli Lilly, Ehrfeld BTS, FDA, Forschung Zentrum Karlsruhe, Fraunhofer ICT, Glaxo SmithKline, Heatric, IMM, Institute for Microchemical Technology, Kyoto University, LG Chem, Lonza, L' Oreal, MCPT, Merck, Mikroglas, Mikroinnova, MIT, Modular Block, Pfizer, Procter & Gamble, Rhodia, Roche, Rohm & Haas, SAFC, Schering, Siemens, Sigma Aldrich, Stevens Institute, Synthacon, Syntics, Syrris, Takada Pharmaceuticals, Technical University Chemnitz, Thomas Swan, Tokyo University, Uhde, Velocys...

Table of Contents

Executive summary

MRT report

• Methodology
• What has happened in 2006?

Introduction to Micro Reaction Technologies (MRT) 26

MRT Market opportunity

• MRT value proposal
• Market segmentation
• Market forecasts for fine chemicals and pharmaceuticals applications
  • R&D market forecasts
  • Production market forecasts
• Focus on fine chemicals & pharmaceuticals market requirements
  • General trends
  • Case studies
• Key success factors for MRT market penetration
  • Expectations of end users
  • Product / Applications matrix
• MRT value chain

Industrial status of development

• Different strategies to go from lab to production
• Conception of MRT equipment
• Technical hurdles

Industry organization and trends

• MRT food chain
• MRT suppliers market shares 2005
• Description of the different business models and case studies
• Involvement of engineering companies

Presentation of MRT products

• Metal / Glass / Ceramics / Plastics MRT modules
• Integrated systems
• Systems under development

Conclusion

Annexes

• 20 company profiles
• Examples of government funded MRT projects